These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 17239022)

  • 41. Melanoma antigen-1 mRNA combined with alpha-fetoprotein mRNA levels in peripheral blood of patients with hepatocellular carcinoma: a predictor of postoperative recurrence or metastasis?
    Zhang Y; Song T; Meng L; Wu X; Ba Y; Li Q
    ANZ J Surg; 2009; 79(1-2):62-9. PubMed ID: 19183381
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma.
    Katz SC; Shia J; Liau KH; Gonen M; Ruo L; Jarnagin WR; Fong Y; D'Angelica MI; Blumgart LH; Dematteo RP
    Ann Surg; 2009 Apr; 249(4):617-23. PubMed ID: 19300227
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Recurrence of hepatocellular carcinoma after liver transplant: patterns and prognosis.
    Roayaie S; Schwartz JD; Sung MW; Emre SH; Miller CM; Gondolesi GE; Krieger NR; Schwartz ME
    Liver Transpl; 2004 Apr; 10(4):534-40. PubMed ID: 15048797
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sirolimus-based immunosuppression therapy in liver transplantation for patients with hepatocellular carcinoma exceeding the Milan criteria.
    Zhou J; Wang Z; Wu ZQ; Qiu SJ; Yu Y; Huang XW; Tang ZY; Fan J
    Transplant Proc; 2008 Dec; 40(10):3548-53. PubMed ID: 19100435
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The timing of liver transplantation after primary hepatectomy for hepatocellular carcinoma: a special reference to recurrence pattern and Milan criteria.
    Ikegami T; Shimada M; Imura S; Yoshizumi T; Arakawa Y; Tokunaga T; Morine Y; Kanemura H
    Transplantation; 2008 Sep; 86(5):641-6. PubMed ID: 18791443
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Superiority of transplantation versus resection for the treatment of small hepatocellular carcinoma.
    Baccarani U; Isola M; Adani GL; Benzoni E; Avellini C; Lorenzin D; Bresadola F; Uzzau A; Risaliti A; Beltrami AP; Soldano F; De Anna D; Bresadola V
    Transpl Int; 2008 Mar; 21(3):247-54. PubMed ID: 18028264
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expanded criteria for liver transplantation in patients with cirrhosis and hepatocellular carcinoma.
    Silva M; Moya A; Berenguer M; Sanjuan F; López-Andujar R; Pareja E; Torres-Quevedo R; Aguilera V; Montalva E; De Juan M; Mattos A; Prieto M; Mir J
    Liver Transpl; 2008 Oct; 14(10):1449-60. PubMed ID: 18825681
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Metachronous resection of metastatic lymph nodes in patients with hepatocellular carcinoma.
    Hashimoto M; Matsuda M; Watanabe G
    Hepatogastroenterology; 2009; 56(91-92):788-92. PubMed ID: 19621703
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Survival after liver transplantation for hepatocellular carcinoma in the model for end-stage liver disease and pre-model for end-stage liver disease eras and the independent impact of hepatitis C virus.
    Thuluvath PJ; Maheshwari A; Thuluvath NP; Nguyen GC; Segev DL
    Liver Transpl; 2009 Jul; 15(7):754-62. PubMed ID: 19562709
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Small-sized liver graft does not increase the risk of hepatocellular carcinoma recurrence after living donor liver transplantation.
    Hwang S; Lee SG; Ahn CS; Kim KH; Moon DB; Ha TY; Park KM; Song GW; Jung DH; Kim BS; Moon KM
    Transplant Proc; 2007 Jun; 39(5):1526-9. PubMed ID: 17580180
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identifying risk for recurrent hepatocellular carcinoma after liver transplantation: implications for surveillance studies and new adjuvant therapies.
    Chan EY; Larson AM; Fix OK; Yeh MM; Levy AE; Bakthavatsalam R; Halldorson JB; Reyes JD; Perkins JD
    Liver Transpl; 2008 Jul; 14(7):956-65. PubMed ID: 18581511
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Solitary large hepatocellular carcinoma: a specific subtype of hepatocellular carcinoma with good outcome after hepatic resection.
    Yang LY; Fang F; Ou DP; Wu W; Zeng ZJ; Wu F
    Ann Surg; 2009 Jan; 249(1):118-23. PubMed ID: 19106686
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Clinical study of adjuvant individualized chemotherapy for hepatocellular carcinoma after liver transplantation].
    Chen GH; Lu MQ; Cai CJ; Yang Y; He XS; Zhu XF
    Zhonghua Wai Ke Za Zhi; 2004 Sep; 42(17):1040-3. PubMed ID: 15498315
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Influence of coexisting cirrhosis on outcomes after partial hepatic resection for hepatocellular carcinoma fulfilling the Milan criteria: an analysis of 293 patients.
    Taura K; Ikai I; Hatano E; Yasuchika K; Nakajima A; Tada M; Seo S; Machimoto T; Uemoto S
    Surgery; 2007 Nov; 142(5):685-94. PubMed ID: 17981188
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cytokeratin 10 and cytokeratin 19: predictive markers for poor prognosis in hepatocellular carcinoma patients after curative resection.
    Yang XR; Xu Y; Shi GM; Fan J; Zhou J; Ji Y; Sun HC; Qiu SJ; Yu B; Gao Q; He YZ; Qin WZ; Chen RX; Yang GH; Wu B; Lu Q; Wu ZQ; Tang ZY
    Clin Cancer Res; 2008 Jun; 14(12):3850-9. PubMed ID: 18559605
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of recurrence of hepatocellular carcinoma after resection in patients with cirrhosis to its occurrence in a surveilled cirrhotic population.
    Cucchetti A; Piscaglia F; Caturelli E; Benvegnù L; Vivarelli M; Ercolani G; Cescon M; Ravaioli M; Grazi GL; Bolondi L; Pinna AD
    Ann Surg Oncol; 2009 Feb; 16(2):413-22. PubMed ID: 19034578
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Radiation therapy for lymph node metastases from hepatocellular carcinoma.
    Toya R; Murakami R; Yasunaga T; Baba Y; Nishimura R; Morishita S; Nishi J; Beppu T; Baba H; Yamashita Y; Oya N
    Hepatogastroenterology; 2009; 56(90):476-80. PubMed ID: 19579624
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expanded criteria for liver transplantation in patients with hepatocellular carcinoma: a report from the International Registry of Hepatic Tumors in Liver Transplantation.
    Onaca N; Davis GL; Goldstein RM; Jennings LW; Klintmalm GB
    Liver Transpl; 2007 Mar; 13(3):391-9. PubMed ID: 17318865
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transarterial chemoembolization before liver transplantation in 60 patients with hepatocellular carcinoma.
    Otto G; Heise M; Moench C; Herber S; Bittinger F; Schuchmann M; Hoppe-Lotichius M; Pitton M
    Transplant Proc; 2007 Mar; 39(2):537-9. PubMed ID: 17362776
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MDR1 gene polymorphisms and risk of recurrence in patients with hepatocellular carcinoma after liver transplantation.
    Wu L; Xu X; Shen J; Xie H; Yu S; Liang T; Wang W; Shen Y; Zhang M; Zheng S
    J Surg Oncol; 2007 Jul; 96(1):62-8. PubMed ID: 17443726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.